Thrombus News and Research

RSS
A blood clot or thrombus, is the final product of the blood coagulation step in hemostasis. It is achieved via the aggregation of platelets that form a platelet plug, and the activation of the humoral coagulation system (i.e. clotting factors).
Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

Plasma myosin light chain 9 levels may be better predictor of COVID-19 severity than blood biomarkers

New diagnostic procedure could help start optimal stroke treatment in a timely manner

New diagnostic procedure could help start optimal stroke treatment in a timely manner

Evaluating serum levels of S100A9 as an inflammatory marker of unfavorable outcomes in patients with COVID-19

Evaluating serum levels of S100A9 as an inflammatory marker of unfavorable outcomes in patients with COVID-19

Robotic surgery reduces readmissions, benefits patients' overall recovery

Robotic surgery reduces readmissions, benefits patients' overall recovery

Free SARS-CoV-2 spike protein fragments may trigger platelet activation and clot formation in COVID-19

Free SARS-CoV-2 spike protein fragments may trigger platelet activation and clot formation in COVID-19

Role of complement factor H-related protein 5 in venous thromboembolism and COVID-19

Role of complement factor H-related protein 5 in venous thromboembolism and COVID-19

New insight about how blood clots are formed during wound healing

New insight about how blood clots are formed during wound healing

Studying coagulopathy in COVID-19

Studying coagulopathy in COVID-19

Scientists decipher molecular cause of cerebral venous thrombosis

Scientists decipher molecular cause of cerebral venous thrombosis

Clinical trial compares Amulet with Watchman FLX device for percutaneous left atrial appendage closure

Clinical trial compares Amulet with Watchman FLX device for percutaneous left atrial appendage closure

Caspase-11 identified as regulator of inflammatory pathology in SARS-CoV-2 infections

Caspase-11 identified as regulator of inflammatory pathology in SARS-CoV-2 infections

Changes in fibrin clot structure contributes to thrombosis risk in severe COVID-19

Changes in fibrin clot structure contributes to thrombosis risk in severe COVID-19

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

RedHill provides opaganib treatment under compassionate use exemption for Swiss COVID-19 patients

Study reveals novel approach to reduce the risk of thrombosis by using IgM antibodies

Study reveals novel approach to reduce the risk of thrombosis by using IgM antibodies

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

DSMB recommends continuation of Phase 2/3 study of opaganib for severe COVID-19

Scientists engineer potent trivalent inhibitors of thrombin

Scientists engineer potent trivalent inhibitors of thrombin

Inhibition of blood clotting factor reduces the formation of brain metastases in mice

Inhibition of blood clotting factor reduces the formation of brain metastases in mice

RedHill Biopharma announces promising preliminary results from opaganib study

RedHill Biopharma announces promising preliminary results from opaganib study

Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures

Aprotinin inhibits SARS-CoV-2 entry and replication in cells cultures

Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients

Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients